SR

Respiratory Function Monitoring for Neonatal Resuscitation: (NLS#806)

profile avatar

ILCOR staff

Commenting on this CoSTR is no longer possible

To read and leave comments, please scroll to the bottom of this page.

This CoSTR is a draft version prepared by ILCOR, with the purpose to allow the public to comment and is labeled “Draft for Public Comment". The comments will be considered by ILCOR. The next version will be labelled “draft" to comply with copyright rules of journals. The final COSTR will be published on this website once a summary article has been published in a scientific Journal and labeled as “final”.

Conflict of Interest Declaration

The ILCOR Continuous Evidence Evaluation process is guided by a rigorous ILCOR Conflict of Interest policy. The following Task Force members and other authors were recused from the discussion as they declared a conflict of interest: None.

The following Task Force members and other authors declared an intellectual conflict of interest and this was acknowledged and managed by the Task Force Chairs and Conflict of Interest committee:

One author (MT) participated in the van Zanten 2021 RCT’s design and protocol development, but was not involved in the execution, data analysis, data interpretation or manuscript preparation. She was excluded from bias assessment of this study. One author (YR) holds patents for pulse oximeter technology to guide oxygen titration in the delivery room. Georg Schmölzer and Peter Davis are the authors of one study {Schmölzer 2012 37}. Both acknowledged their potential intellectual conflicts of interest and participated in the Task Force discussion of the consensus on science and treatment recommendations.

CoSTR Citation

Fuerch JH, Rabi Y, Thio M, Halamek LP, Costa-Nobre DT, de Almeida MF, Davis PG, El-Naggar W, Fabres JG, Fawke J, Nakwa FL, Foglia EE, Guinsburg R, Hosono S, Isayama T, Kapadia VS, Kawakami MD, Kim HS, Lee H, Madar RJ, McKinlay C, Perlman JM, Roehr CC, Rüdiger M, Schmölzer GM, Sugiura T, Trevisanuto D, Weiner GM, Wyllie JP, Liley HG, Wyckoff MH. Respiratory Function Monitoring (NLS#806 [Internet] Brussels, Belgium. International Liaison Committee on Resuscitation (ILCOR) Neonatal Life Support Task Force, Available from http://ilcor.org

Methodological Preamble (and Link to Published Systematic Review)

This PICOST was prioritized by the Neonatal Life Support Task Force because the question had not been updated since 2015. The literature search for the previous CoSTR {Perlman 2015 S204} had found only one eligible study that used a device to assess respiratory function based in a small (n=49) pilot RCT, resulting in low certainty evidence (downgraded for risk of bias and imprecision) {Schmölzer 2012 37}. No evidence was found regarding time to heart rate >100 bpm, neurologically intact survival, bronchopulmonary dysplasia or pneumothorax. Treatment recommendation suggested against the routine use of flow and volume monitoring for babies receiving positive pressure ventilation at birth, until more evidence became available.

The task force was aware that additional randomized trials examining the use of a respiratory function monitor device had been completed since the previous review. The above mentioned RCT has also been included in the current CoSTR {Schmölzer 2012 377; Zeballos Sarrato 2019 1368; van Zanten 2021 317}.

The continuous evidence process for the creation of Consensus of Science and Treatment Recommendations (CoSTR) started with a systematic review of respiratory function monitoring in the delivery room (Rabi, 2021 PROSPERO 2021 CRD42021278169) conducted by Janene H. Fuerch, Yacov Rabi, Marta Thio, and Louis P. Halamek. Evidence from neonatal literature was sought and considered by the Neonatal Life Support Task Force and clinical content experts. These data were considered when formulating the Treatment Recommendations.

Systematic Review

Not yet available.

PICOST

The PICOST (Population, Intervention, Comparator, Outcome, Study Designs, and Time Frame)

Population: In newborn infants receiving respiratory support at birth

Intervention: does the display of respiratory function monitoring (RFM)

Comparator: no display of RFM

Outcomes: Improve resuscitation [time to HR > 100bpm in delivery room (starting from birth), achieving desired tidal volumes (TV) in the delivery room (measure of respiratory function), percentage maximum mask leak in the delivery room (while using facemask ventilation), rate of intubation in the delivery room, air leaks (pneumothorax, pneumomediastinum, pneumopericardium, pulmonary interstitial emphysema) reported either individually or as a composite outcome within 24 hours of delivery], and/or improve clinical outcomes [death before discharge, severe Intraventricular hemorrhage (IVH) grades 3 or 4, bronchopulmonary dysplasia (BPD) / chronic lung disease (CLD) (any), duration of respiratory support, (i.e. nasal continuous airway pressure and ventilation via an endotracheal tube considered separately and in total (number of days))].

Outcomes ratings using the GRADE classifications of critical or important were based on a consensus for international neonatal resuscitation guidelines (range 1-3 low importance for decision-making, 4-6 important but not critical for decision-making, 7-9 critical for decision-making) {Strand 2020 328}. No subgroups were defined a priori. Outcomes were converted into main outcomes and additional outcomes for submission to PROSPERO. All included randomized controlled trials (RCTs) compared an RFM that was visible to the resuscitator versus one that was masked. If necessary, study authors were contacted to request missing data.

Study Designs: RCTs, quasi-RCTs, and non-randomized studies (non-randomized controlled trials, interrupted time series, controlled before-and-after studies, cohort studies) were eligible for inclusion. Unpublished studies (e.g., conference abstracts, trial protocols) were excluded. Outcomes from observational studies were assessed if there were fewer than 2 included RCTs/quasi-RCTs or if the certainty of evidence from RCTs/quasi-RCTs was scored very low.

Timeframe: All years and all languages were included as long as there was an English abstract. The literature search was updated to December 31, 2021.

PROSPERO registration:

The review was registered with PROSPERO CRD42021278169.

Risk of Bias:

Risk of bias (RoB) was assessed by outcome using the Cochrane ROB2 tool {Sterne 2019 366} for RCTs. RoB for each outcome was summarized across studies. Statistical heterogeneity was considered present if the I2 statistic was >50%. Imprecision was considered present if the confidence interval for the estimate of effect was wide and/or if the total number of participants included was less than optimal information size (OIS) for the outcome under consideration. OIS was calculated as the sample size required for a single, adequately powered RCT {Dupont 1974 274}.

Overall, study-level RoB was high. The ability to view the RFM was an intervention of interest and did not serve as a major plausible risk of performance bias from a lack of blinding the healthcare provider, as might otherwise be expected. However, some concerns regarding the blinding of participants and personnel. The risk of bias for outcome assessment was low because the analysis and interpretation of outcomes were conducted by researchers blinded to the group allocation. Zeballos Sarrato et.al. listed this primary outcome as tidal volume in the trial protocol (US ClinicalTrials.gov PRS, ID:NCT02748720) while they reported the primary outcome as need for surfactant, therefore the trial had some concerns for selective reporting {Zeballos Sarrato 2019 1368}. Schmölzer et.al. had unclear risk of selective reporting as there were some secondary outcomes in the trial registry that were not reported in the manuscript {Schmölzer 2012 377}.

All outcomes selected for GRADE assessment, were rated as very low or low certainty evidence. For most outcomes, this uncertainty was attributable to the risk of bias described above and imprecision.

Consensus on Science

COMPARISON: Display of respiratory function monitoring compared with no respiratory function monitoring display during neonatal resuscitation immediately after birth.

The systematic review identified 3 RCTs {Schmölzer 2012 377; Zeballos Sarrato 2019 1368; van Zanten 2021 317}, involving 443 newborns. One newborn infant died in the delivery room in the van Zanten et.al study which accounted for the total of 443 newborns, there is one less newborn reported in many of the longer-term outcomes due to this death.

In response to resuscitation:

For the important outcome intubation in the delivery room, evidence of very low certainty (downgraded for risk of bias, inconsistency and imprecision) from 3 randomized controlled trials (RCTs) {Schmölzer 2012 377; Zeballos Sarrato 2019 1368; van Zanten 2021 317} involving 443 patients could not exclude clinical benefit or harm from displaying a respiratory function monitor compared to not displaying a respiratory function monitor (RR 0.90, 95% CI 0.55 – 1.48; p=0.69; I2 = 61%).

For the important outcome of achieving desired tidal volumes in the delivery room, evidence of low certainty (downgraded for risk of bias and imprecision) from 2 RCTs {Schmölzer 2012 377; van Zanten 2021 317} involving 337 patients could not exclude clinical benefit or harm from displaying a respiratory function monitor compared to not displaying a respiratory function monitor (RR 0.96, 95% confidence interval (CI) 0.69 – 1.34; p=0.8; I2 = 0%).

For the important outcome of pneumothorax, evidence of low certainty (downgraded for risk of bias and imprecision) from 2 RCTs {Zeballos Sarrato 2019 1368; van Zanten 2021 317} involving 393 patients could not exclude clinical benefit or harm from displaying a respiratory function monitor compared to not displaying a respiratory function monitor (RR 0.54, 95% CI 0.26 – 1.13; p=0.10; I2 = 0%).

For the important outcome of time to heart rate >100bpm in the delivery room, no data were reported in the included studies.

For the outcome of face-mask leak, the 3 RCTs could not be meta-analyzed as the measurement of leak was reported differently in each study. One trial reported median (IQR) percentage of leak per infant and found less leak when RFM was displayed (p=0.01) {Schmölzer 2012 377}. Another trial reported percentage of leak >75% over all inflations and found less leak when RFM was displayed (p=0.001) {Zeballos Sarrato 2019 1368}. The third and largest trial reported median (IQR) percentage of leak >60% per infant and found no significant difference in leak (p=0.126) between RFM displayed and the RFM not displayed {van Zanten 2021 317}.

Longer-term clinical outcomes:

For the critical outcome of death before hospital discharge, evidence of low certainty (downgraded for risk of bias and imprecision) from 3 RCTs {Schmölzer 2012 377; Zeballos Sarrato 2019 1368; van Zanten 2021 317} involving 442 patients could not exclude clinical benefit or harm from displaying a respiratory function monitor compared to not displaying a respiratory function monitor (RR 1.00 95% CI 0.66 – 1.52; p=0.99; I2 = 0%).

For the critical outcome of severe intraventricular hemorrhage (grades 3 or 4), evidence of low certainty (downgraded for risk of bias and imprecision) from 1 RCT {van Zanten 2021 317} involving 287 patients could not exclude clinical benefit or harm from displaying a respiratory function monitor compared to not displaying a respiratory function monitor (RR 0.96 95% CI 0.38 – 2.42; p=0.93). Statistical heterogeneity could not be calculated because events occurred in only one trial {van Zanten 2021 317}.


For the important outcome of intraventricular hemorrhage (all grades), evidence of low certainty (downgraded for risk of bias and imprecision) from 2 RCTs {Zeballos Sarrato 2019 1368; van Zanten 2021 317} involving 393 patients suggests possible clinical benefit from displaying a respiratory function monitor compared to not displaying a respiratory function monitor (RR 0.69 95% CI 0.49-0.96; p=0.03; I2 = 0%).

For the important outcome of bronchopulmonary dysplasia/chronic lung disease (any), evidence of low certainty (downgraded for risk of bias and imprecision) from 2 RCTs {Zeballos Sarrato 2019 1368, van Zanten 2021 317} involving 393 patients could not exclude clinical benefit or harm from displaying a respiratory function monitor compared to not displaying a respiratory function monitor (RR 0.85 95% CI 0.7 – 1.04; p=0.12; I2 = 0%).

Subgroup Analyses:

No subgroup analyses were pre-planned or performed.

Treatment Recommendations

There is insufficient evidence to make a recommendation for or against the use of a respiratory function monitor in newborn infants receiving respiratory support at birth (low certainty evidence).

Justification and Evidence to Decision Framework Highlights

In making this recommendation, the Neonatal Life Support Task Force acknowledges the following:

For newborn infants who receive respiratory support at birth, the Task Force did not make a recommendation for or against the use of a respiratory function monitor in part because of the low confidence in effect estimates for either benefit or harm (low certainty evidence).

One study reported the proportion of infants with tidal volume >8mL/kg {Zeballos Sarrato, 2019 1368} showing less excessive tidal volume when using RFM in infants <30 weeks' gestation (p<0.001 in n=21 infants 28-29 weeks' gestation, p<0.001 in n=51 infants <28 weeks' gestation). However, this was a post hoc analysis with relatively few patients and, therefore, did not influence our treatment recommendation.

Intraventricular hemorrhage (all grades), but not severe IVH, was statistically significantly decreased in the RFM visible group (low certainty). However, there is a lack of certainty whether the difference in IVH between groups in 2 RCTs (n=393 patients) was attributable to the RFM or a chance finding as IVH (all grades) was one of many secondary outcomes. The composite outcome of IVH (all grades) and periventricular leukomalacia (PVL) was not considered for this recommendation as it was a post-hoc secondary outcome.

No specific device cost or training cost were reported in these trials. However, the cost of purchasing and implementing new devices is significant. In addition, there are several human factor issues that should be addressed if RFM use were to become more widespread.

The lack of clinical benefit, except the possible benefit in reducing intraventricular hemorrhage (all grades), and the lack of cost-effectiveness data, contributed to the recommendation statement.

Knowledge Gaps

Research priorities should include human factor assessment, methods exploring opportunities to reduce inequity, and cost-benefit analysis. Standardized operational definitions for outcomes in future studies would permit meta-analysis of results such as mask leak.

Potential research questions are listed below:

Does the use of a RFM vs no RFM during neonatal resuscitation in the delivery room result in a difference in the percentage of time spent delivering a target tidal volume? [What is the definition of clinically significant mask leak (in terms of % leak and % of time spent with that degree of leak)?]

Does the use of a RFM vs no RFM during neonatal resuscitation in the delivery room result in a faster time to a heart rate > 60 (and > 100bpm)?

What is the optimal manner in which RFM data and alarms should be displayed to achieve its most accurate and timely acquisition, interpretation and translation to actionable information?

What are the training requirements to achieve and maintain competency in the acquisition and accurate interpretation of data derived from RFM during neonatal resuscitation?

What is the cost effectiveness for the use of RFM (vs no RFM) during neonatal resuscitation?

Attachments: NLS 806 RFM Et D

References

  1. Dupont WD and Plummer WD: PS power and sample size program available for free on the Internet. Controlled Clin Trials,1997;18:274
  2. Perlman JM, Wyllie J, Kattwinkel J et.al. Part 7: Neonatal Resuscitation. 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation.2015;132:S204-241.
  3. Schmölzer GM, Morley CJ, Wong C, et al. Respiratory function monitor guidance of mask ventilation in the delivery room: a feasibility study. J Pediatr. 2012;160(3):377-381.e2.
  4. Sterne JAC, Savovic J, Page MJ et.al. RoB 2: a revised tool for assessing risk of bias in randomized trials. BMJ. 2019;366:I4898.
  5. Strand ML, Simon WM, Wyllie J, Wyckoff MH, Weiner G. Consensus outcome rating for international neonatal resuscitation guidelines. Arch Dis Child Fetal Neonatal Ed.2020;105:328-330.
  6. van Zanten HA, Kuypers KLAM, van Zwet EW, van Vonderen JJ, Kamlin COF, Springer L, Lista G, Cavigioli F, Vento M, Núñez-Ramiro A, Oberthuer A, Kribs A, Kuester H, Horn S, Weinberg DD, Foglia EE, Morley CJ, Davis PG, Te Pas AB. A multi-centre randomised controlled trial of respiratory function monitoring during stabilisation of very preterm infants at birth. Resuscitation. 2021 Oct;167:317-325.
  7. Zeballos Sarrato G, Sánchez Luna M, Pérez Pérez A, et al. New Strategies of Pulmonary Protection of Preterm Infants in the Delivery Room with the Respiratory Function Monitoring. Amer J Perinatol. 2019;1–9.

Discussion

GUEST
Anasuya Nagaraj
I agree that the RFM may not alter the outcome ,needs training of personnel . also it may take away the concentration of the resuscitator where time is of utmost importance especially in smaller places/centers
Reply
GUEST
Marcela Damásio Ribeiro de Castro
The cost of purchasing and implementing new devices may be, no doubt, an obstacle.
Reply
GUEST
ANENISIA ANDRADE
I do not see clear evidence to support the implementation of RFM in the deliver room.
Reply
GUEST
Mariza Pereira da silva
I do not see clear evidence to support the implementation of RFM in the deliver room.
GUEST
Liza Edmonds
While the technology for the use of respiratory monitoring might one day be accessible and portable it will need to be considered in the future. I agree that without the evidence it would suggest it is not ready to become a routine part of resuscitation.
Reply
GUEST
Roger Brock
The evolution of the newborn, (general status, breathing, skin color, heart rate, should determine the necessary or not follow-up with monitoring
Reply
GUEST
Amanda Freitas
The cost of a respiratory function monitor in the delivery room is very high and can delay or hinder resuscitation maneuvers when used by teams poorly trained with the equipment.
Reply
GUEST
Marcos Silva
Respiratory rate does not seem to be a safe parameter in the assessment of decision-making during resuscitation because it can be erratic, causing confusion in the assessment and delay in ventilation.
Reply
GUEST
Mônica Teixeira
I think that neonatal reanimation is supposed to be a fast (about 10 to 20 minutes) and automated dynamic and the HR monitoring in the Delivery Room may slow it down. For that reason, my opinion is that it is unnecessary in the DR.
Reply
GUEST
Manuela Abreu E Lima
It seems that it is not a cost-effective tool (cost outweighs the benefit)
Reply
GUEST
Jaqueline Tonelotto
I agree. I think the use of ECG is more important than monitoring respiratory function, because we need limited financial resource and we need to practice the good evidences
Reply
GUEST
Colin Morley
Conflicts of interest: Speakers bureau
Prof Colin Morley MD FRCP 23 High Street, Great Shelford, Cambridge CB22 5EH February 18th 2022 Following the call for public comments below are my thoughts and comments about ILCOR NLS-806-RFM-EtD Respiratory Function Monitoring for Neonatal Resuscitation I was surprised by the recommendation, “There is insufficient evidence to make a recommendation for or against the use of a respiratory function monitor in newborn infants receiving respiratory support at birth (low certainty evidence)”. After an extensive search of the literature, I found 227 papers about monitoring neonatal resuscitations in different ways. It is likely that I have missed some. This may be more than publications and evidence about other individual neonatal resuscitation techniques. I appreciate that the main evidence you look for are randomised controlled trials. However, when these are small, few and possibly biased in various ways it does not seem appropriate to completely ignore other evidence that has accumulated over the years such as animal and observational studies. The basis of medicine is a good understanding of physiology which underpins clinical studies. We should not ignore that. Observational studies may not be strong evidence on their own but when there are many of them all showing similar things then they should be acknowledged and used. A problem with just using randomised trials of monitoring in neonatal resuscitation is that those using a monitor must be trained and experienced in interpreting the data and ensure they look at the monitor and recognise any problems and know how to change the ventilation technique. One of the things that has been commented about using a monitor is that good training is important. People interpreting CTGs, ECGs, chest x-rays etc, and even driving a car, will not be able to do it properly without detailed training. Before a detailed study of resuscitation monitoring, it is vital that we can trust the resuscitators have been trained to use it properly. It has been suggested that watching a monitor distracts the resuscitator from looking at the baby. A problem with the subjective observations and assessments that are recommended in NRP and NLS is they are frequently inaccurate, can’t always help and may be misleading. Important aspects of neonatal resuscitation like mask leak, airway opening, head position and tidal volume can’t be assessed by observation. These can only be determined by monitoring and measuring. Neonatologists will be well trained in the Neonatal Resuscitation Program, Neonatal Life Support program, or similar, which teach resuscitation management largely from observation. This may influence the resuscitators to want to look at the baby rather than a monitor even though the monitor is showing them objective data of what is happening. A problem with RCTs in neonatal resuscitation is that some outcomes e.g. rate of intubation and surfactant treatment may be strongly influenced by training and local protocols and this may affect the results. The RCT in the ILCOR review, by Schmölzer GM, et. “Respiratory function monitor guidance of mask ventilation in the delivery room: a feasibility study”. J Pediatr; 2012 was designed to investigate whether a monitor reduced mask leak and was powered for that. It was associated with significantly less mask leak from 54% to 37%, more adjustments of mask position and airway pressure, and a lower rate of an expiratory tidal volume <8 ml/kg. Using a Resuscitation monitor was not associated with any obvious problems. The RCT by Zeballos Sarrato, “New Strategies of Pulmonary Protection of Preterm Infants in the Delivery Room with the Respiratory Function Monitoring” showed the median expiratory tidal volumes during inflations were greater in the monitor masked group (7 mL/kg) than in the visible group (5.8 mL/kg; p = 0.001). Similarly, the peak inflation pressure was (21.5 vs. 19.7 cmH2O; p < 0.001). No problems with using the monitor were reported. The RCT by van Zantan did not show any differences in outcome between the groups in particular the expired tidal volume was similar in both groups. No problems with using the monitor were reported but in answer to specific post hoc questions the resuscitators thought that more training would be helpful. In the ILCOR document The term “respiratory function monitor” is not described or defined in this document. Inexperienced readers need to know what they measure and why they might be considered useful. Monitors in use, or have been used, are: Respironics NM3, Acutronic Florian, Novametrix Ventcheck, Monivent, ResusRight, NICO CO2 monitor, Newborn resuscitation monitor (Laerdal), Augmented infant resuscitator, Next Step monitor. They do not measure the same parameters in the same way. The recommendation is, “There is insufficient evidence to make a recommendation for or against the use of a respiratory function monitor”. I suggest there is no evidence that using a respiratory function monitor causes problems and that should be clarified. There are suggestions in the ILCOR review, set out below, which are interesting and important, but most are very difficult to achieve because of the difficulties with this sort of research. If ILCOR is to demand this data and outcomes before resuscitation monitoring is recommended, then these criteria should be applied to other parts of the neonatal resuscitation algorithm which are based on little or no research data. “If respiratory function monitoring is implemented, clinical outcome monitoring should continue, for both short term (e.g. face-mask leak, time to HR >100 bpm, TV within desired range and outside the range) and long term clinical outcomes (e.g. BPD, neurodevelopment impairment).” “Research priorities should include human factor assessment, methods exploring opportunities to reduce inequity, and cost-benefit analysis. Standardized operational definitions for outcomes in future studies would permit meta-analysis of results such as mask leak.” “We anticipate implementing RFM into routine clinical practice would require significant training and cost. In addition, there are human factor issues that need to be addressed should RFM be more widespread (see Research priorities section below). Cost of any new treatment or intervention is important but difficult to calculate in the resuscitation of mainly very preterm babies because of so many other confounding factors. It is important to realise that if the use of a Respiratory monitor was to reduce serious handicap the expense of the monitor could easily be cover by saving in the treatment and care costs of such a child. If ILCOR is to demand this data and outcomes before resuscitation monitoring is recommended, then these criteria should be applied to other parts of the neonatal resuscitation algorithm, some of which, are based on little or no research data. After an extensive review of the literature, I found 227 papers about monitoring neonatal resuscitations. I have roughly categorised them: 110 were either about monitoring respiratory parameters or about oxygenation 52 papers were monitoring studies with manikins, 17 were monitoring studies with animals, 26 studies where video recordings were predominantly used, 14 were studies concentrating on expired CO2, 16 were reviews. The titles and abstracts of all these paper can be Obtained from colin@morleys.net. Before you print it you should know there are 100 pages! While considering this review it is important to appreciate the following about resuscitation and respiratory monitoring before it can’t be recommended: 1. Respiratory monitoring is not a new concept. It is an integral part of modern ventilators, both adult and neonatal, measuring and displaying gas flow, inspiratory and expiratory tidal volumes, inflation and expiration times, ventilation pressures and spontaneous breathing. 2. Respiratory monitoring is a fundamental part of the care of mechanically ventilated patients in operating rooms and intensive care units (ICUs) including neonatal intensive care units and so it is already being used. Although surprisingly it is not used at one of the most important and difficult times – resuscitation at birth. 3. Neonatal resuscitation training teaches little about measurement, recording and display of physiological parameters rather it emphasises subjective observations like watching chest rise as an assessment of tidal volume even though this has been shown to be very inaccurate. This has not been the subject of a detailed and stringent review as is being suggested for monitoring. 4. Neonatal resuscitation training also recommends of a set inflating pressures to use even though there is good data that these have little relationship with the delivered tidal volume which is strongly affected by: a baby’s size, gestation, the use of antenatal steroids, volume of lung fluid present, respiratory efforts of the baby, gas leak at the mask or endotracheal tube, laryngeal obstruction of the airway, depressant drugs, equipment used, and experience of the resuscitator. This has not been the subject of a detailed and stringent review as being used for monitoring. There is little recommendation in the training to measure or control tidal volumes. 5. There is increasing data that lung injury in very preterm babies is related to high or low tidal volumes from the positive pressure ventilation used. 6. The MRSOPA mnemonic suggests treatment assessment and changes if treatment is not working such as: Mask adjustment, repositioning the head and neck, suction mouth and nose, opening the mouth, increasing the airway pressure, and using an alternative airway. These are all done on subjective assessments of the effect of the original treatment and effect of any changes. It would be more accurate and appropriate if these were measured. The 227 papers I found highlight the following about monitoring neonatal physiological signals and videos of resuscitations. The sentences below have been taken verbatim from the conclusions in some of the papers. Information about ventilation events and ventilation parameters could potentially be useful during a resuscitation situation by giving immediate feedback to the health care provider. Recording and reviewing vital physiological parameters and video imaging of neonatal resuscitation in the delivery room is a valuable tool for quality assurance, education and research and improve the quality of neonatal resuscitation provided. Recording and reviewing neonatal resuscitation is considered highly beneficial for learning and improving resuscitation skills and is recommended by providers participating in it. During mask ventilation, resuscitators were unable to accurately assess chest wall movement visually from either head or side view. Facemask leak is large during resuscitation of preterm infants using round silicone masks. Tidal volumes delivered during PPV inflations are much higher than those generated during spontaneous breathing by an infant on CPAP. High VT delivery during mask PPV at birth was associated with brain injury. Strategies to limit VT delivery during mask PPV should be used to prevent high VT delivery. Using an RFM was associated with significantly less mask leak, more mask adjustments, and a lower rate of excessive expired tidal volume. A difficult part of neonatal resuscitation is subjectively assessing spontaneous breathing. 1. Providing effective PPV seems easy. However, performing the procedure correctly is extremely challenging. Airway obstruction and face mask large leaks are common. It is estimated that two-thirds of continued neonatal respiratory depression after the time of birth is caused by ineffective or improperly provided PPV. 2. Airway obstruction and face-mask leak are common during the first 2 min of PPV. An RFM enables detection of important airway obstruction and mask leaks. 3. Laryngeal closure impedes non-invasive iPPV at birth and may reduce the effectiveness of non-invasive respiratory support in premature infants immediately after birth. (This would not have been recognised without physiological monitoring) 4. Initial resuscitation via an endotracheal tube, using currently recommended pressures, rarely produced adequate tidal volumes. Resuscitation via an endotracheal tube or a face mask was most effective when the infant's inspiratory effort coincided with an inflation. 5. Substantial tidal volume changes occur before, during and after surfactant administration in the delivery room. Complete airway obstruction is common. Monitoring respiratory function during this procedure may help to assess the delivered tidal volume and airway pressures after surfactant treatment. 6. In 56% of the neonatal resuscitations interruptions in ventilation are frequent with 60% ventilation fraction during the first 30s of PPV. Eliminating disruption for improved quality of PPV delivery should be emphasized when training newborn resuscitation providers. 7. A flow sensor would improve the assessment of successful endotracheal tube placement with a higher success rate and a shorter time compared with an ETCO2 detector. 8. Two-person mask ventilation technique reduces mask leak by approximately 50% compared to the standard one-person mask ventilation method. 9. Video recording identified strengths and weaknesses in the performance of neonatal resuscitation and can facilitate targeted education and quality assurance programmes. 10. Prolonging inflation times during face mask resuscitation of prematurely born infants did not improve ventilation as prolonged inflation did not lead to longer inflation flow times. 11. Expired tidal volumes were significantly greater if the infant inspired during the inflation. 12. Training with a simple RFM significantly reduced the occurrence of excessive PIP and expired tidal volumes 13. EtCO2 monitoring in the DR did not reduce the proportion of admission PCO2 levels outside of the prespecified range in a population of infants supported mostly with noninvasive ventilation. 14. Data have shawn that ECO2 levels can indicate the relative degree of lung aeration after birth and can be used to clinically assess ventilation in the immediate newborn period. 15. Observing tidal volume and ECO2 waveforms adds objectivity to clinical assessments. ECO2 could help assess lung aeration and improve lung recruitment immediately after birth. 16. Infants with congenital diaphragmatic hernia, particularly those who have undergone fetoscopic endoluminal tracheal occlusion have a low lung compliance at birth, and this is further reduced by administration of a neuromuscular blocking agent. 17. Facemask leak is large during resuscitation of preterm infants using round silicone masks. Tidal volumes delivered during PPV inflations are much higher than those generated during spontaneous breathing by an infant on CPAP. 18. Face mask obstruction is common during PPV of preterm infants in the DR. Oropharyngeal airways are associated with significantly higher rates of partial obstruction. 19. Most preterm infants breathe when receiving mask ventilation and this probably contributes to the stabilization of the infants after birth. 20. The 50th percentile for spontaneous tidal volume in preterm infants during mask CPAP ranged from 4.2 to 5.8 mL/kg, with wide individual variation observed in the first minutes after birth. 21. Positive pressure ventilation, guided by VT and EtCO2, potentially optimize lung aeration without excessive tidal volume administered. 22. A sustained inflation of 10 seconds at 25 cmH2O in preterm infants at birth was not effective unless infants breathed. The speculation is that active glottic adduction may be responsible for most ventilation failures. 23. Recordings of physiological parameters and video imaging can improve documentation by providing detailed information. 24. The use of a nasal tube led to large leak, more obstruction, and inadequate tidal volumes compared with face mask. 25. Expiratory volumes were higher, mask leakage lower, and mean airway pressure slightly higher with upright versus standard resuscitator when ventilating a manikin. 26. Directly after birth, ductal shunting is influenced by breathing effort, predominantly with an increase in left-to-right shunt due to inspiration. 27. Tidal volume is highly variable during the anaesthetic care of neonates, and potentially injurious tidal volume is frequently delivered; thus, we suggest close tidal volume monitoring using a dedicated neonatal RFM. 28. Video recording was well-accepted by the staff, useful for objective assessment of performance during resuscitation, and can be used as an educational tool in a low-resource setting. 29. Video recording of neonatal resuscitations, as a standard of care quality assurance activity to enhance caregivers’ learning and create opportunities that improve patient safety is feasible. 30. A video study showed the more corrective ventilation strategies employed the greater the need for intubation. 31. Video recording enables information about adherence to guidelines, technical, behavioural and communication skills within the resuscitation team. 32. ECG may not be reliable and other monitoring, such as cardiac ultrasound and PO, may offer more benefit. 33. Very preterm infants breathe at birth when receiving PPV, but the respiratory effort was significantly lower when compared with infants receiving CPAP only. The reduced breathing effort observed likely justified applying PPV in most infants. 34. This study provides reference ranges of exhaled carbon dioxide, exhaled tidal volumes, and respiratory rate for the first ten minutes after birth in term infants who transition without resuscitation. 35. Two models of self-inflating bags could not provide safe minimum tidal volumes (2.5-5 mL); six models exceeded safety inflation pressure limit >45 cm H2O, representing 6% of their inflations 36. Prenatal caffeine infusion had no significant effect on acute haemodynamic parameters in ventilated preterm lambs during the cardiorespiratory transition. 37. ECG may be inaccurate during resuscitation after asphyxia. 38. Tactile stimulation showed a significant increase in SpO2 in preterm infants. 39. Recording and reviewing neonatal resuscitation is considered highly beneficial for learning and improving resuscitation skills and is recommended by providers participating in it. 40. Wearable eye-tracking technology is feasible to identify gaze fixation on the respiratory monitor display and is well accepted by providers. Neonatal providers look at exhaled tidal volume more than any other parameter. 41. The display of information from an RFM improved the effectiveness of newborn facemask ventilation training. 42. Ventilation correction interventions recommended by the MRSOPA mnemonic improved tidal volume delivery in some cases, but lead to ineffective or excessive tidal volumes in others. Mask leak and obstruction can be induced by MRSOPA manoeuvres. 43. Adding video-debriefing to standard Helping-Babies-Breathe training had an effect on birth attendants' competence attainment and retention over 6 months in Uganda. 44. Parents consider reviewing recordings of neonatal resuscitation as valuable. These positive parental experiences could allay concerns about sharing recordings of neonatal resuscitation with parents. 45. Facemask placement in term and late-preterm infants during neonatal stabilisation are associated with apnoea and this effect is more pronounced after the first compared with subsequent applications. 46. At birth, neonates innately brake expiratory flow to defend FRC gains and redistribute gas to less aerated regions. Yours sincerely, Colin Morley
Reply
Andrea Lube
(6 posts)
I believe that with the development of new technologies that are easier to use, the monitoring of respiratory function will bring benefits in the future. In any case, training the team to use the equipment is essential. For services where financial resources are scarce, ventilation training, with clinical quality assessment is what will make a difference in the results.
Reply
GUEST
Silvia Heloisa Moscatel Loffredo
I believe that more evidence is needed on the benefits of using a respiratory function monitor in neonatal resuscitation to justify the purchase of expensive equipment.
Reply

Sort by

Time range

Categories

Domains

Status

Review Type